December 4, 2018
We conducted successful testing and run-through of the study protocol for our novel technology RESPINOR DXT with our principal investigator from Paris, Alexandre Demoule. This feasibility study will commence early in the New Year.
-
RESPINOR: MedTech innovator specializing in diaphragm monitoring, introducing DXT, a non-invasive ultrasound-based technology to improve critical care and outcomes.